Literature DB >> 2073989

Immunotherapy in pre-type 1 diabetes mellitus.

J F Bach, J Dupré, G S Eisenbarth, L C Harrison, N K Maclaren, J Nerup, P Pozzilli.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2073989     DOI： 10.1007/BF00400349

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

1.  Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group.

Authors: 
Journal:  Diabetes       Date:  1988-11       Impact factor: 9.461

2.  Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus.

Authors:  J Silverstein; N Maclaren; W Riley; R Spillar; D Radjenovic; S Johnson
Journal:  N Engl J Med       Date:  1988-09-08       Impact factor: 91.245

3.  First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion.

Authors:  S Srikanta; O P Ganda; A Rabizadeh; J S Soeldner; G S Eisenbarth
Journal:  N Engl J Med       Date:  1985-08-22       Impact factor: 91.245

4.  Predicting insulin-dependent diabetes.

Authors:  A C Tarn; J M Thomas; B M Dean; D Ingram; G Schwarz; G F Bottazzo; E A Gale
Journal:  Lancet       Date:  1988-04-16       Impact factor: 79.321

5.  Factors associated with early remission of type I diabetes in children treated with cyclosporine.

Authors:  P F Bougneres; J C Carel; L Castano; C Boitard; J P Gardin; P Landais; J Hors; M J Mihatsch; M Paillard; J L Chaussain
Journal:  N Engl J Med       Date:  1988-03-17       Impact factor: 91.245

6.  Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes.

Authors:  J J Cook; I Hudson; L C Harrison; B Dean; P G Colman; G A Werther; G L Warne; J M Court
Journal:  Diabetes       Date:  1989-06       Impact factor: 9.461
  6 in total
  1 in total

1.  Epidemiological and ethical consiluations on trials with immunotherapy in pre-type 1 (insulin-dependent) diabetes mellitus.

Authors:  G Dahlqvist
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.